GeoVax Labs, Inc. New
Symbol: GOVX (NASDAQ)
0.69
▼ (-0.44%) -0.003
Company Description:
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
Key Stats
- Today's Open: $0.69
- Today's High: $0.691
- Today's Low: $0.67
- Today's Volume: 516.17K
- Yesterday Close: $0.689
- Yesterday High: $0.69155
- Yesterday Low: $0.67825
- Yesterday Volume: 465.17K
- Last Min Volume: 2
- Last Min High: $0.686
- Last Min Low: $0.686
- Last Min VWAP: $0.686
Company Profile
- Name: GeoVax Labs, Inc. New
- Website: https://www.geovax.com
- Listed Date: 1995-02-01
- Location: SMYRNA, GA
- Market Status: Active
- CIK Number: 0000832489
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $17.69M
- Round Lot: 100
- Outstanding Shares: 25.36M
- Asset Type: CS
RECENT FILINGS FOR GOVX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-08 | 4 | View |
| 2025-08-01 | 8-K | View |
| 2025-07-29 | 8-K | View |
| 2025-07-29 | 424B3 | View |
| 2025-07-29 | 424B3 | View |
| 2025-07-29 | 424B3 | View |
| 2025-07-29 | 424B3 | View |
| 2025-07-29 | 424B3 | View |
| 2025-07-28 | 10-Q | View |
| 2025-07-08 | SCHEDULE 13G | View |
| 2025-07-07 | SCHEDULE 13G | View |
| 2025-07-02 | 8-K | View |
| 2025-07-02 | 424B4 | View |
| 2025-06-30 | EFFECT | View |
| 2025-06-30 | CORRESP | View |
| 2025-06-27 | CORRESP | View |
| 2025-06-26 | S-1/A | View |
| 2025-06-25 | CORRESP | View |
| 2025-06-23 | CORRESP | View |
Latest News on GOVX